中東およびアフリカのバイオプロセス市場予測 - 2031年まで - 地域分析 - 製品別(機器および消耗品および付属品)、事業規模別(商業事業および臨床事業)、プロセス別(下流バイオプロセスおよび上流バイオプロセス)、用途別(モノクローナル抗体、ワクチン、組み換えタンパク質、細胞および遺伝子治療など)、およびエンドユーザー別(バイオ医薬品会社、契約製造組織など)

BMIRE00030825 | Pages: 139 | Biotechnology | Oct 2024 | Type: Regional | Status: Published

中東およびアフリカのバイオプロセス市場は、2023年に3億1,437万米ドルと評価され、2031年までに7億2,554万米ドルに達すると予想されています。また、2023年から2031年にかけて11.0%のCAGRを記録すると予測されています。

自動化された細胞療法製造への移行が中東およびアフリカのバイオプロセス市場を後押し

細胞療法の増加により、細胞療法製品の生産は世界中で少量から大量へと移行しています。細胞療法の研究活動の増加により、高度な製造ソリューションの需要が高まっています。これを考慮して、多くのプレーヤーが学術研究者や大手バイオテクノロジー企業のニーズを満たす製品を提供しています。たとえば、Lonza CocoonやMiltenyiのCliniMACS Prodigyシステムは、CAR-Tプロセスのほとんどの連続ユニット操作を単一のシステム内で自動化できるように設計されています。さらに、細胞療法の進化(学術および臨床現場から大量生産および商業化へ)により、製造の自動化の需要が高まっています。2019年5月、GEヘルスケアは、細胞療法のワークフロー全体をサポートするクロニクルウェブアプリケーションをリリースしました。クロニクル自動化ソフトウェアは、複雑な細胞療法プロセスの開発と製造を最適化するように設計された、適正製造基準に準拠したデジタルソリューションです。企業は、細胞療法の自動化のための戦略的および技術的開発にも参入しています。たとえば、2020年7月、サーモフィッシャーサイエンティフィック社とライエルイムノファーマ社は、がん患者に効果的な細胞療法を設計するためのプロセスの開発と製造で提携しました。この提携の下、両社はT細胞の適応性を向上させ、試薬、消耗品、機器とともに、統合されたcGMP準拠プラットフォーム(システムとソフトウェア)の開発をサポートすることを目指しています。2019年3月、ロンザはイスラエルのシェバ医療センターと提携し、ポイントオブケアのコクーン細胞療法製造プラットフォームを使用して、自動化されたクローズドCAR-T製造を提供しました。自動化された手順により、製造コストを大幅に削減し、スタッフの生産性と定着率を高めることができます。これらの要因以外にも、自動化されたプロセスは製造ユニット内のさまざまな汚染源を制限し、最終的にはプロセスの一貫性を高め、手作業によるエラーを減らすことで全体的に高品質の製品を生み出します。したがって、細胞療法メーカーによる自動化の採用の増加と細胞療法の分野での製品革新の増加は、細胞療法のバイオプロセスまたは製造を促進する可能性があります。

中東およびアフリカのバイオプロセス市場の概要

中東およびアフリカのバイオプロセス市場は、サウジアラビア、UAE、南アフリカ、およびその他の中東およびアフリカに分割されています。サウジアラビアは、中東およびアフリカで最大の市場シェアを占めています。この地域の市場を牽引するいくつかの要因は、がんの罹患率の増加、免疫疾患の発生率の増加、政府による好ましい取り組み、研究開発活動の急増です。サウジアラビアの省庁は、国内に生産施設を設立するためにバイオテクノロジー企業と契約を結んでいます。これに沿って、国際企業が中東およびアフリカでのプレゼンスを強化するために採用している拡大戦略は、今後数年間でバイオプロセス市場に利益をもたらすと予想されます。

中東およびアフリカのバイオプロセス市場の収益と2031年までの予測(百万米ドル)

中東およびアフリカのバイオプロセス市場のセグメンテーション

中東およびアフリカのバイオプロセス市場は、製品、運用規模、プロセス、アプリケーション、エンドユーザー、および国に分類されています。

製品に基づいて、中東およびアフリカのバイオプロセス市場は、機器と消耗品およびアクセサリに分かれています。 機器セグメントは、2023年に大きな市場シェアを占めました。 さらに、機器セグメントは、ろ過装置、バイオリアクター、クロマトグラフィーシステム、遠心分離機、乾燥装置などにサブセグメント化されています。 さらに、バイオリアクターのサブセグメントは、パイロットスケール、フルスケール、およびラボスケールに分類されます。 さらに、サブセグメントのクロマトグラフィーシステムは、液体クロマトグラフィー、ガスクロマトグラフィーなどにセグメント化されています。さらに、消耗品および付属品セグメントは、試薬、細胞培養培地、クロマトグラフィー樹脂などに細分化されています。

事業規模の面では、中東およびアフリカのバイオプロセシング市場は、商業事業と臨床事業に分かれています。 商業事業セグメントは、2023年に大きな市場シェアを占めました。

プロセス別に見ると、中東およびアフリカのバイオプロセシング市場は、下流バイオプロセスと上流バイオプロセスに分かれています。 下流バイオプロセスセグメントは、2023年に大きな市場シェアを占めました。

用途別に見ると、中東およびアフリカのバイオプロセシング市場は、モノクローナル抗体、ワクチン、組み換えタンパク質、細胞および遺伝子治療などに分類されています。 モノクローナル抗体セグメントは、2023年に最大の市場シェアを占めました。

エンドユーザーの観点から見ると、中東およびアフリカのバイオプロセシング市場は、バイオ医薬品会社、契約製造組織などに分類されています。バイオ医薬品企業セグメントは、2023年に最大の市場シェアを占めました。

国別に見ると、中東およびアフリカのバイオプロセス市場は、サウジアラビア、南アフリカ、UAE、その他の中東およびアフリカに分かれています。サウジアラビアは、2023年に中東およびアフリカのバイオプロセス市場シェアを独占しました。

Getinge AB、Thermo Fisher Scientific Inc、Sartorius AG、Corning Inc、Bio-Rad Laboratories Inc、Merck KGaA、3M Co、Eppendorf SE、Agilent Technologies Inc、およびCytiva US LLCは、中東およびアフリカのバイオプロセス市場で事業を展開している大手企業の一部です。

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodologys

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Bioprocessing Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Chronic Diseases

4.1.2 Growing Biopharmaceutical Industry

4.2 Market Restraints

4.2.1 Stringent Regulatory Policies and Limitations Associated with Bioprocessing

4.3 Market Opportunities

4.3.1 Proliferating Demand for Personalized Medicine

4.4 Future Trends

4.4.1 Shift Toward Automated Cell Therapy Manufacturing

4.5 Impact of Drivers and Restraints:

5. Bioprocessing Market - Middle East & Africa Analysis

5.1 Middle East & Africa Bioprocessing Market Overview

5.2 Bioprocessing Market Revenue (US$ Million), 2021-2031

6. Middle East & Africa Bioprocessing Market Analysis - by Product

6.1 Overview

6.2 Instruments

6.2.1 Overview

6.2.2 Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

6.2.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments

6.2.2.1.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors

6.2.2.1.2 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems

6.3 Consumables & Accessories

6.3.1 Overview

6.3.2 Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

6.3.2.1 Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

7. Middle East & Africa Bioprocessing Market Analysis - by Scale of Operation

7.1 Overview

7.2 Commercial Operations

7.2.1 Overview

7.2.2 Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

7.3 Clinical Operations

7.3.1 Overview

7.3.2 Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

8. Middle East & Africa Bioprocessing Market Analysis - by Process

8.1 Overview

8.2 Downstream Bioprocess

8.2.1 Overview

8.2.2 Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

8.3 Upstream Bioprocess

8.3.1 Overview

8.3.2 Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9. Middle East & Africa Bioprocessing Market Analysis - by Application

9.1 Overview

9.2 Monoclonal Antibodies

9.2.1 Overview

9.2.2 Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9.3 Vaccines

9.3.1 Overview

9.3.2 Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9.4 Recombinant Protein

9.4.1 Overview

9.4.2 Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9.5 Cell & Gene Therapy

9.5.1 Overview

9.5.2 Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10. Middle East & Africa Bioprocessing Market Analysis - by End User

10.1 Overview

10.2 Biopharmaceutical Companies

10.2.1 Overview

10.2.2 Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.3 Contract Manufacturing Organization

10.3.1 Overview

10.3.2 Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

10.4 Others

10.4.1 Overview

10.4.2 Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11. Middle East & Africa Bioprocessing Market - Country Analysis

11.1 Middle East & Africa

11.1.1 Middle East & Africa: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)

11.1.1.1 Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.1.1 Overview

11.1.1.2 Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.2.1 Saudi Arabia: Bioprocessing Market Breakdown, by Product

11.1.1.2.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Instruments

11.1.1.2.1.1.1 Saudi Arabia: Bioprocessing Market Breakdown, by Bioreactors

11.1.1.2.1.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Chromatography Systems

11.1.1.2.1.2 Saudi Arabia: Bioprocessing Market Breakdown, by Consumables & Accessories

11.1.1.2.2 Saudi Arabia: Bioprocessing Market Breakdown, by Scale of Operation

11.1.1.2.3 Saudi Arabia: Bioprocessing Market Breakdown, by Process

11.1.1.2.4 Saudi Arabia: Bioprocessing Market Breakdown, by Application

11.1.1.2.5 Saudi Arabia: Bioprocessing Market Breakdown, by End User

11.1.1.3 South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.3.1 Overview

11.1.1.4 South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.4.1 South Africa: Bioprocessing Market Breakdown, by Product

11.1.1.4.1.1 South Africa: Bioprocessing Market Breakdown, by Instruments

11.1.1.4.1.1.1 South Africa: Bioprocessing Market Breakdown, by Bioreactors

11.1.1.4.1.1.2 South Africa: Bioprocessing Market Breakdown, by Chromatography Systems

11.1.1.4.1.2 South Africa: Bioprocessing Market Breakdown, by Consumables & Accessories

11.1.1.4.2 South Africa: Bioprocessing Market Breakdown, by Scale of Operation

11.1.1.4.3 South Africa: Bioprocessing Market Breakdown, by Process

11.1.1.4.4 South Africa: Bioprocessing Market Breakdown, by Application

11.1.1.4.5 South Africa: Bioprocessing Market Breakdown, by End User

11.1.1.5 United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.5.1 Overview

11.1.1.6 United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.6.1 United Arab Emirates: Bioprocessing Market Breakdown, by Product

11.1.1.6.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Instruments

11.1.1.6.1.1.1 United Arab Emirates: Bioprocessing Market Breakdown, by Bioreactors

11.1.1.6.1.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Chromatography Systems

11.1.1.6.1.2 United Arab Emirates: Bioprocessing Market Breakdown, by Consumables & Accessories

11.1.1.6.2 United Arab Emirates: Bioprocessing Market Breakdown, by Scale of Operation

11.1.1.6.3 United Arab Emirates: Bioprocessing Market Breakdown, by Process

11.1.1.6.4 United Arab Emirates: Bioprocessing Market Breakdown, by Application

11.1.1.6.5 United Arab Emirates: Bioprocessing Market Breakdown, by End User

11.1.1.7 Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.7.1 Overview

11.1.1.8 Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

11.1.1.8.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Product

11.1.1.8.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Instruments

11.1.1.8.1.1.1 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Bioreactors

11.1.1.8.1.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Chromatography Systems

11.1.1.8.1.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Consumables & Accessories

11.1.1.8.2 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Scale of Operation

11.1.1.8.3 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Process

11.1.1.8.4 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by Application

11.1.1.8.5 Rest of Middle East & Africa: Bioprocessing Market Breakdown, by End User

12. Industry Landscape

12.1 Overview

12.2 Growth Strategies in the Bioprocessing Market

12.3 Inorganic Growth Strategies

12.3.1 Overview

12.4 Organic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 Getinge AB

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Thermo Fisher Scientific Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Sartorius AG

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Corning Inc

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Bio-Rad Laboratories Inc

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Merck KGaA

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 3M Co

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Eppendorf SE

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Agilent Technologies Inc

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Cytiva US LLC

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

 

 

?

List of Tables

Table 1. Middle East & Africa Bioprocessing Market Segmentation

Table 2. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Instruments

Table 3. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Bioreactors

Table 4. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Chromatography Systems

Table 5. Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - By Consumables & Accessories

Table 6. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 7. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 8. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 9. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 10. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 11. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 12. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 13. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 14. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 15. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 16. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 17. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 18. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 19. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 20. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 21. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 22. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 23. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 24. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 25. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 26. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 27. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 28. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 29. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 30. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 31. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 32. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 33. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Product

Table 34. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Instruments

Table 35. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Bioreactors

Table 36. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Chromatography Systems

Table 37. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Consumables & Accessories

Table 38. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Scale of Operation

Table 39. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Process

Table 40. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by Application

Table 41. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million) - by End User

Table 42. Recent Inorganic Growth Strategies in the Bioprocessing Market

Table 43. Recent Organic Growth Strategies in the Bioprocessing Market

Table 44. Glossary of Terms, Bioprocessing Market

 

?

List of Figures

Figure 1. Middle East & Africa Bioprocessing Market Segmentation, by Country

Figure 2. Bioprocessing Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Bioprocessing Market Revenue (US$ Million), 2021-2031

Figure 5. Bioprocessing Market Share (%) - by Product (2023 and 2031)

Figure 6. Instruments: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 7. Consumables & Accessories: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 8. Bioprocessing Market Share (%) - by Scale of Operation (2023 and 2031)

Figure 9. Commercial Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 10. Clinical Operations: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 11. Bioprocessing Market Share (%) - by Process (2023 and 2031)

Figure 12. Downstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 13. Upstream Bioprocess: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 14. Bioprocessing Market Share (%) - by Application (2023 and 2031)

Figure 15. Monoclonal Antibodies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 16. Vaccines: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 17. Recombinant Protein: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 18. Cell & Gene Therapy: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 19. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 20. Bioprocessing Market Share (%) - by End User (2023 and 2031)

Figure 21. Biopharmaceutical Companies: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 22. Contract Manufacturing Organization: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 23. Others: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 24. Middle East & Africa: Bioprocessing Market, by Key Country - Revenue (2023) (US$ Million)

Figure 25. Middle East & Africa: Bioprocessing Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 26. Saudi Arabia: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 27. South Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 28. United Arab Emirates: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 29. Rest of Middle East & Africa: Bioprocessing Market - Revenue and Forecast to 2031 (US$ Million)

Figure 30. Growth Strategies in the Bioprocessing Market

  1. Getinge AB
  2. Thermo Fisher Scientific Inc
  3. Sartorius AG
  4. Corning Inc
  5. Bio-Rad Laboratories Inc
  6. Merck KGaA
  7. 3M Co
  8. Eppendorf SE
  9. Agilent Technologies Inc
  10. Cytiva US LLC.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa bioprocessing market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa bioprocessing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa bioprocessing market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2485
Site License
$4550
$3185
Enterprise License
$5550
$3885